02/11/26

Exploratory Cancer-Related Diagnostic Excellence Measures.

Agency for Healthcare Research and Quality.

Summary

Developing diagnostic excellence measures is vital for tracking progress and identifying process weaknesses. This guidance draft outlines cancer-related measures from the AHRQ Quality Indicators Program, focusing on timely follow-up after screening, late-stage diagnoses, and new diagnoses following acute presentations to guide system-level safety improvements.

Exploratory Cancer-Related Diagnostic Excellence Measures. Agency for Healthcare Research and Quality. February 11, 2026.